Sufentanil "Hameln" 5 mikrogram/ml injektions-/infusionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

sufentanil "hameln" 5 mikrogram/ml injektions-/infusionsvæske, opløsning

hameln pharma gmbh - sufentanilcitrat - injektions-/infusionsvæske, opløsning - 5 mikrogram/ml

Temgesic 0,2 mg resoribletter, sublinguale Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

temgesic 0,2 mg resoribletter, sublinguale

eumedica pharmaceuticals gmbh - buprenorphinhydrochlorid - resoribletter, sublinguale - 0,2 mg

Temgesic 0,4 mg resoribletter, sublinguale Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

temgesic 0,4 mg resoribletter, sublinguale

eumedica pharmaceuticals gmbh - buprenorphinhydrochlorid - resoribletter, sublinguale - 0,4 mg

Thiotepa Riemser Den Europæiske Union - dansk - EMA (European Medicines Agency)

thiotepa riemser

esteve pharmaceuticals gmbh - thiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastiske midler - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.

Oxycodone "Hameln" 10 mg/ml injektions-/infusionsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

oxycodone "hameln" 10 mg/ml injektions-/infusionsvæske, opløsning

hameln pharma gmbh - oxycodonhydrochlorid - injektions-/infusionsvæske, opløsning - 10 mg/ml

Axura Den Europæiske Union - dansk - EMA (European Medicines Agency)

axura

merz pharmaceuticals gmbh - memantinhydrochlorid - alzheimers sygdom - andre anti-demensmidler - behandling af patienter med moderat til svær alzheimers sygdom.